Vascular Disease and Dementia: Lipoprotein(a) as a Neglected Link

Giuseppe Lippi; Elisa Danese; Emmanuel J. Favaloro

doi:10.1055/s-0039-1687907

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2019; 45(05): 544-547
DOI: 10.1055/s-0039-1687907

Letter to the Editor

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Vascular Disease and Dementia: Lipoprotein(a) as a Neglected Link

Authors

Giuseppe Lippi

¹Section of Clinical Biochemistry, University of Verona, Verona, Italy
Elisa Danese

¹Section of Clinical Biochemistry, University of Verona, Verona, Italy
Emmanuel J. Favaloro

²Department of Haematology, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia

Abstract

Volltext

Referenzen

References
1 de Mello Gomide Loures C, Figueiredo Duarte RC, Ferreira Silva MV. , et al. Hemostatic abnormalities in dementia: a systematic review and meta-analysis. Semin Thromb Hemost 2019; 45 (05) 514-522
2 Montagnana M, Lippi G, Danese E. An overview of thrombophilia and associated laboratory testing. Methods Mol Biol 2017; 1646: 113-135
3 Lippi G, Guidi G. Lipoprotein(a): from ancestral benefit to modern pathogen?. QJM 2000; 93 (02) 75-84
4 Lippi G, Franchini M, Salvagno GL, Guidi GC. Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency. Cancer Treat Rev 2007; 33 (05) 427-436
5 Urakami K, Mura T, Takahashi K. Lp(a) lipoprotein in cerebrovascular disease and dementia. Jpn J Psychiatry Neurol 1987; 41 (04) 743-748
6 Kuriyama M, Hokezu Y, Togo S. , et al. Serum lipids, lipoproteins and apolipoproteins in patients with senile dementia [in Japanese]. Nippon Ronen Igakkai Zasshi 1992; 29 (7-8): 559-564
7 Caramelli P, Nitrini R, Maranhão R. , et al. Increased apolipoprotein B serum concentration in Alzheimer's disease. Acta Neurol Scand 1999; 100 (01) 61-63
8 Urakami K, Wada-Isoe K, Wakutani Y. , et al. Lipoprotein(a) phenotypes in patients with vascular dementia. Dement Geriatr Cogn Disord 2000; 11 (03) 135-138
9 Mooser V, Helbecque N, Miklossy J, Marcovina SM, Nicod P, Amouyel P. Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease. Ann Intern Med 2000; 132 (07) 533-537
10 Zuliani G, Ble' A, Zanca R. , et al. Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease. BMC Geriatr 2001; 1: 5
11 Solfrizzi V, Panza F, D'Introno A. , et al. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 72 (06) 732-736
12 Emanuele E, Peros E, Tomaino C. , et al. Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans. Neurosci Lett 2003; 353 (03) 201-204
13 Emanuele E, Peros E, Tomaino C. , et al. Relation of apolipoprotein(a) size to Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 2004; 18 (02) 189-196
14 Emanuele E, Peros E, Tomaino C. , et al. Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease. Neurosci Lett 2004; 357 (01) 45-48
15 Iwamoto T, Watanabe D, Umahara T. , et al. Dual inverse effects of lipoprotein(a) on the dementia process in Japanese late-onset Alzheimer's disease. Psychogeriatrics 2004; 4 (06) 64-71
16 Watanabe T, Koba S, Kawamura M. , et al. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism 2004; 53 (04) 476-482
17 Pantoni L, Sarti C, Pescini F. , et al. Thrombophilic risk factors and unusual clinical features in three Italian CADASIL patients. Eur J Neurol 2004; 11 (11) 782-787
18 Cankurtaran M, Yavuz BB, Halil M, Dagli N, Cankurtaran ES, Ariogul S. Are serum lipid and lipoprotein levels related to dementia?. Arch Gerontol Geriatr 2005; 41 (01) 31-39
19 Ban Y, Watanabe T, Suguro T. , et al. Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia. J Atheroscler Thromb 2009; 16 (03) 179-187
20 Gong M, Rueschendorf F, Marx P. , et al. Clinical and genetic features in a family with CADASIL and high lipoprotein (a) values. J Neurol 2010; 257 (08) 1240-1245
21 Valenti R, Nannucci S, Pescini F, Bianchi S, Inzitari D, Pantoni L. High lipoprotein(a) serum levels in three CADASIL families. J Neurol 2012; 259 (02) 379-380
22 Ray L, Khemka VK, Behera P. , et al. Serum homocysteine, dehydroepiandrosterone sulphate and lipoprotein (a) in Alzheimer's disease and vascular dementia. Aging Dis 2013; 4 (02) 57-64
23 Kunutsor SK, Khan H, Nyyssönen K, Laukkanen JA. Is lipoprotein (a) protective of dementia?. Eur J Epidemiol 2016; 31 (11) 1149-1152
24 Sarti C, Pantoni L, Pracucci G, Di Carlo A, Vanni P, Inzitari D. ; Italian Longitudinal Study on Aging (ILSA). Lipoprotein(a) and cognitive performances in an elderly white population: cross-sectional and follow-up data. Stroke 2001; 32 (07) 1678-1683
25 Iemolo F, Duro G, Rizzo C, Castiglia L, Hachinski V, Caruso C. Pathophysiology of vascular dementia. Immun Ageing 2009; 6: 13
26 Kotani K, Serban MC, Penson P, Lippi G, Banach M. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - Some answers and still many questions. Crit Rev Clin Lab Sci 2016; 53 (06) 370-378
27 Riches K, Porter KE. Lipoprotein(a): cellular effects and molecular mechanisms. Cholesterol 2012; 2012: 923289
28 Zuliani G, Cavalieri M, Galvani M. , et al. Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. J Neurol Sci 2008; 272 (1-2): 164-170
29 Dentali F, Gessi V, Marcucci R, Gianni M, Grandi AM, Franchini M. Lipoprotein(a) as a risk factor for venous thromboembolism: a systematic review and meta-analysis of the literature. Semin Thromb Hemost 2017; 43 (06) 614-620
30 Anglés-Cano E, de la Peña Díaz A, Loyau S. Inhibition of fibrinolysis by lipoprotein(a). Ann N Y Acad Sci 2001; 936: 261-275
31 Sevush S, Jy W, Horstman LL, Mao WW, Kolodny L, Ahn YS. Platelet activation in Alzheimer disease. Arch Neurol 1998; 55 (04) 530-536
32 Takechi R, Galloway S, Pallebage-Gamarallage M, Wellington C, Johnsen R, Mamo JC. Three-dimensional colocalization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP/PS1 transgenic mice. Histochem Cell Biol 2009; 131 (05) 661-666
33 Leung YY, Toledo JB, Nefedov A. , et al. Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study. Alzheimers Dement (Amst) 2015; 1 (03) 339-348
34 Lippi G, Targher G, Salvagno GL, Montagnana M, Franchini M, Guidi GC. Lipoprotein(a) and ageing. Clin Lab 2010; 56 (9-10): 463-466